It is IBFM’s mission to advance the knowledge of childhood cancer biology and to translate this from bench to bedside into more effective treatments.
It is IBFM’s mission to advance the knowledge of childhood cancer biology and to translate this from bench to bedside into more effective treatments.
IBFM’s objectives include:
Fostering information exchange among the participating groups, including preliminary results;
Promoting research projects in childhood leukemias, lymphomas and related disorders, including non-Hodgkin’s lymphomas;
Supporting prospective randomized clinical trials, using consensus approaches and allowing the participation of other groups;
Initiating cooperative research projects for a better understanding of pediatric cancers’ biology;
Encouraging a quick and accurate translation of findings from basic to clinical research, and vice versa;
Achieving a better understanding of very rare hematological malignancies.
Improve lives of children and adolescents with leukemia and lymphoma
Better understand and translate research findings into better cures
Foster information exchange among dedicated research groups
Make clinical research the key to better and safer treatments
Home
About Us
News and Announcements
Structure
Activities
History
Clinical trials
Contact & links
Professor Arndt Borkhardt and Dr. Melina Mescher
Department of Paediatric Oncology, Haematology and Clinical Immunology
Medical Faculty, Heinrich-Heine-University Duesseldorf
Moorenstraße 5
40225 Düsseldorf, Germany
melinamonika.mescher@med.uni-duesseldorf.de
I-BFM-SG © All rights reserved Copyrights 2024